Dolphin Intertrade Corporation recalls XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
Recalled April 30, 2014 · FDA recall D-1250-2014 · Dolphin Intertrade
Hazard
Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs. · FDA Class I
Units
8 bottles
Sold at
Nationwide
Description
Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Product
XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
Manufacturer(s)
Dolphin Intertrade Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →